Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02616107 · ClinicalTrials.gov registry record · NA
Improving Cancer Family Caregivers' Knowledge and Communication About Care Options
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02616107: Completed NA study, sponsored by Yale University.
NCT02616107 is a NA study that has completed, run by Yale University. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02616107, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this two-year mixed methods study is to develop and test an intervention to improve cancer family caregivers' knowledge of care options (curative, palliative, and hospice care) and goals of care communication as part of a self-management (SM) training program. The two specific aims of this project are to: 1. Develop a psycho-educational intervention called Managing Cancer Care: A Caregiver's Guide (MCC-CG), for family caregivers of patients with breast cancer to increase knowledge of care options, goals of care communication, and other SM skills. 2. Evaluate the feasibility and preliminary efficacy of the MCC-CG in a pilot randomized controlled trial compared with an attention-control condition (symptom management education) on knowledge of care options, goals of care communication, and other key SM skills (engagement in SM, management of transitions and uncertainty, increasing self-efficacy, appropriate use of health care resources).
Primary Outcome
11-item questionnaire in true/false format to assess knowledge of curative, palliative, and hospice care.
Interventions
- OTHER Managing Cancer Care: A Caregiver's Guide
- OTHER Symptom Management Toolkit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02616107 record still lists
NCT02616107 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Managing Cancer Care: A Caregiver's Guide is the first listed.
NCT02616107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02616107 about?
NCT02616107 is a clinical study titled "Improving Cancer Family Caregivers' Knowledge and Communication About Care Options". The purpose of this two-year mixed methods study is to develop and test an intervention to improve cancer family caregivers' knowledge of care options (curative, palliative, and hospice care) and goals of care communication as part of a self-management (SM) training program. The two specific aims o...
What is the current status of trial NCT02616107?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2014-07. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02616107?
The interventions under investigation include: Managing Cancer Care: A Caregiver's Guide (OTHER), Symptom Management Toolkit (OTHER).
Who is sponsoring clinical trial NCT02616107?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02616107's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia